Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

226 10 The Immune System in Cancer: If It Isn't Broken, Can We Fix It?
Sioud M, Forre O, Capra JD, Natvig
JB. Peptide recognition, T cell receptor
usage and HLA restriction elements
of human heat-shock protein (hsp) 60
and mycobacterial 65-kDa hsp-reactive
T cell clones from rheumatoid synovial
fluid. Eur J Immunol 1992; 22: 1315±
1322.
23 Lucey DR, Clerici M, Shearer GM.
Type 1 and type 2 cytokine dysregulation
in human infectious, neoplastic,
and inflammatory diseases. Clin Microbiol
Rev 1996; 9: 532±562.
24 Segal BM, Klinman DM, Shevach EM.
Microbial products induce autoimmune
disease by an IL-12-dependent pathway.
J Immunol 1997; 158: 5087±5090.
25 Brackertz D, Mitchell GF, Mackay
IR. Antigen-induced arthritis in
mice. I. Induction of arthritis in various
strains of mice. Arthritis Rheum 1977;
20: 841±850.
26 Esquivel PS, Rose NR, Kong YC. Induction
of autoimmunity in good and
poor responder mice with mouse thyroglobulin
and lipopolysaccharide. J Exp
Med 1977; 145: 1250±1263.
27 Chiller JM, Skidmore BJ, Morrison
DC,Weigle WO. Relationship of
the structure of bacterial lipopolysaccharides
to its function in mitogenesis
and adjuvanticity. Proc Natl Acad Sci
USA 1973; 70: 2129±2133.
28 Dell A, Antone SM, Gauntt CJ,
Crossley CA, Clark WA, Bunningham
MW. Autoimmune determinants
of rheumatic carditis: localisation of
epitopes in human cardiac myosin. Eur
Heart J 1991; 12: 158±162.
29 Kearney ER, Pape KA, Loh DY, Jenkins
MK. Visualization of peptide-specific
T cell immunity and peripheral tolerance
induction in vivo. Immunity
1994; 1: 327±339.
30 Vella AT, Mitchell T, Groth B, Linsley
PS, Green JM, Thompson CB, Kappler
JW, Marrack P. CD28 engagement
and proinflammatory cytokines
contribute to T cell expansion and longterm
survival in vivo. J Immunol 1997;
158: 4714±4720.
31 Bowne WB, Srinivasan R, Wolchok
JD, Hawkins WG, Blachere NE,
Dyall R, Lewis JJ, Houghton AN.
Coupling and uncoupling of tumor immunity
and autoimmunity. J Exp Med
1999; 190: 1717±1722.
32 Houghton AN. Cancer antigens: immune
recognition of self and altered
self. J Exp Med 1994; 180: 1±4.
33 Golumbek P, Levitsky H, Jaffee E,
Pardoll DM. The antitumor immune
response as a problem of self±nonself
discrimination: implications for immunotherapy.
Immunol Res 1993; 12: 183±
192.
34 Pardoll DM. Inducing autoimmune
disease to treat cancer. Proc Natl Acad
Sci USA 1999; 96: 5340±5342.
35 Parmiani G. Tumor immunity as autoimmunity:
tumor antigens include normal
self proteins which stimulate anergic
peripheral T cells. Immunol Today
1993; 14: 536±538.
36 Naftzger C, Takechi Y, Kohda H,
Hara I,Vijayasaradhi S, Houghton
AN. Immune response to a differentiation
antigen induced by altered
antigen: a study of tumor rejection and
autoimmunity. Proc Natl Acad Sci USA
1996; 93: 14809±14814.
37 Matzinger P. An innate sense of danger.
Semin Immunol 1998; 10: 399±415.
38 Harlan DM, Hengartner H,
Huang ML, Kang YH, Abe R, Moreadith
RW, Pircher H, Gray GS,
Ohashi PS, Freeman GJ, Nadler LM,
June CH, Aichele P. Mice expressing
both B7±1 and viral glycoprotein on
pancreatic b cells along with glycoprotein-specific
transgenic T cells develop
diabetes due to a breakdown of
T-lymphocyte unresponsiveness. Proc
Natl Acad Sci USA 1994; 91: 3137±
3141.
39 Overwijk WW, Lee DS, Surman DR,
Irvine KR, Touloukian CE, Chan C,
Carroll MW, Moss B, Rosenberg SA,
Restifo NP. Vaccination with a recombinant
vaccinia virus encoding a self
antigen induced autoimmune vitiligo
and tumor cell destruction in mice: requirement
for CD4 + T lymphocytes.
Proc Natl Acad Sci USA 1999; 96: 2982±
2987.
40 Vile RG, Castleden SC, Upton C,
Chong HC. Gene therapy for cancer
using a combination of cytotoxic and